Updated my numbers (Table below) given the contract and SP moves...

Updated my numbers (Table below) given the contract and SP moves of peers of late. The original post as linked in which these metrics are repeated in column SP1 below. SP2 uses the TCV/ARR metrics as at the original post (Oct 18) but updated for current valuations of peers. SP3 uses the latest TCV/ARR metrics and updated valuations. IME has become relatively cheaper with the SP down whilst they have grown TCV by ~80% and ARR by  ~50%. Another ASX peer to note is M7T (PACs & VNA product with ARR of $5.3m), which is left out as it appears to be similar to IME (i.e. earlier stage and less known to investors) thus would skew valuations lower.